HC Wainwright & Co. Maintains Buy on NeuroPace, Lowers Price Target to $12

Benzinga · 1d ago
HC Wainwright & Co. analyst Yi Chen maintains NeuroPace (NASDAQ:NPCE) with a Buy and lowers the price target from $20 to $12.